Myriad Genetics

High Beta Large Cap Growth Stock Picks From Decatur Capital Management Yield Market Returns Way...

67 WALL STREET, New York - November 18, 2009 - The Wall Street Transcript has recently published its 4th Quarter 2009 TWST Large Cap Growth Report offering a timely review of the sector to serious investors and industry...

powered by

Stock research report available on Myriad Genetics (NASDAQ:MYGN) from SmarTrend Analytics

Nov 17, 2009 (SmarTrend(R) Research Reports via COMTEX) -- SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:MYGN) at...

powered by

Myriad Genetics to Present at the 21st Annual Piper Jaffray Health Care Conference

SALT LAKE CITY, Nov. 17, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at the 21st Annual Piper Jaffray...

powered by

Patents on breast cancer genes are illegal and stymie research, say scientists

1 New York A US court is allowing a lawsuit to proceed against the US Patent Office and a biotechnology company regarding the legality of patents awarded for two breast cancer genes. In a case that may have far reaching...

powered by

Zacks Bull and Bear of the Day Highlights: Infosys, Myriad Genetics Inc., American International...

We are upgrading Infosys (NasdaqGS: INFY - Through the ongoing economic downturn, the company has invested in Research & Development as well as intellectual property-based solutions. Myriad Genetics spun off its therapeutics...

powered by

Myriad Pharma Posts Smaller 1Q Loss After Spinoff

Myriad Pharma reports lower research and development costs in 1st quarter after spinoff SALT LAKE CITY November 13, 2009 (AP) The Associated Press Post a Comment Myriad Pharmaceuticals Inc. on Friday reported a smaller fiscal...

powered by

J.C. Penney, Disney, Genzyme are big movers

— The following stocks were among those that moved substantially or traded heavily Friday on the New York Stock Exchange: The department store retailer posted a 78 percent drop in its third-quarter earnings because of a big...

powered by

Myriad Genetics upgraded by Morgan Joseph (Briefing.com)

To learn more about Yahoo!'s use of personal information, please read the Privacy Policy. Analyst Summary Information (upgrades/downgrades module) provided by Briefing.com. All information provided "as is" for informational...

powered by

Smartphones And Internet Ads Drive Top Line Growth And Fuel Stock Picks From Kellogg Asset...

67 WALL STREET, New York - The Wall Street Transcript has just published its TWST Large Cap Growth Report offering a timely review of the sector to serious investors and industry executives. MARK P. HILGENDORF, CFA is Director...

powered by

Gene patents pose ethical dilemma

Corporate monopolies hamper research Austin Peasly The Daily Evergreen The advancement of scientific ethics won a small victory Wednesday when a move to dismiss a patent case against Myriad Genetics was overturned in a New York...

powered by
1 2 3 4 5 next »